stockportfolio.pro
Haemonetics Corporation EPS (Earnings per Share) 2009–2026
Haemonetics Corporation (HAE) annual earnings per share by fiscal year, computed from SEC filings. Compound growth +3.5%/yr over 17 years.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2026 | $2.05 | -38.1% |
| FY 2025 | $3.31 | +44.5% |
| FY 2024 | $2.29 | +2.2% |
| FY 2023 | $2.24 | +166.7% |
| FY 2022 | $0.84 | -45.8% |
| FY 2021 | $1.55 | +4.7% |
| FY 2020 | $1.48 | +42.3% |
| FY 2019 | $1.04 | +22.4% |
| FY 2018 | $0.85 | +266.7% |
| FY 2017 | $-0.51 | +53.2% |
| FY 2016 | $-1.09 | -440.6% |
| FY 2015 | $0.32 | -52.2% |
| FY 2014 | $0.67 | -9.5% |
| FY 2013 | $0.74 | -43.1% |
| FY 2012 | $1.30 | -16.7% |
| FY 2011 | $1.56 | +39.3% |
| FY 2010 | $1.12 | -1.3% |
| FY 2009 | $1.14 | — |
Source: Haemonetics Corporation SEC filings — income statement (10-K), split-adjusted. Refreshed nightly.
See the full picture for Haemonetics Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeHaemonetics Corporation — frequently asked questions
What is Haemonetics Corporation's earnings per share?
Haemonetics Corporation (HAE) reported earnings per share of $2.05 for fiscal year 2026, per its SEC filings.
How has Haemonetics Corporation's earnings per share changed over time?
Between fiscal 2009 and 2026, HAE's earnings per share grew at roughly 3.5% per year (compound annual rate), from $1.14 to $2.05.
Where does this data come from?
Figures are computed from Haemonetics Corporation's official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.